Study identifier:NIS-CTH-DUM-2007/1
ClinicalTrials.gov identifier:N/A
EudraCT identifier:N/A
CTIS identifier:N/A
Lipid-lowering therapy in patients with high cardiovascular risk and their 3-year mortality rate in general practice in Thailand
Dyslipidemia
-
No
-
All
1240
Observational
20 Years - 80 Years
Allocation: -
Endpoint Classification: -
Intervention Model: -
Masking: -
Primary Purpose: -
Verified 01 Jan 2015 by AstraZeneca Pharmaceuticals
AstraZeneca Pharmaceuticals
-
No locations available
Arms | Assigned Interventions |
---|---|
1 Patients with high cardiovascular risk who have been treated with lipid-lowering drugs at least 3 months | - |